Olema Pharmaceuticals, Inc. (OLMA)
10.27
-0.52
(-4.82%)
USD |
NASDAQ |
Aug 28, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Shareholders Equity (Quarterly) : 430.56M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 430.56M |
| March 31, 2026 | 480.48M |
| December 31, 2025 | 478.56M |
| September 30, 2025 | 307.49M |
| June 30, 2025 | 345.24M |
| March 31, 2025 | 383.45M |
| December 31, 2024 | 408.96M |
| September 30, 2024 | 198.91M |
| June 30, 2024 | 227.16M |
| March 31, 2024 | 236.32M |
| December 31, 2023 | 253.90M |
| September 30, 2023 | 275.13M |
| Date | Value |
|---|---|
| June 30, 2023 | 161.58M |
| March 31, 2023 | 174.98M |
| December 31, 2022 | 197.55M |
| September 30, 2022 | 217.70M |
| June 30, 2022 | 236.28M |
| March 31, 2022 | 265.09M |
| December 31, 2021 | 284.57M |
| September 30, 2021 | 300.89M |
| June 30, 2021 | 314.08M |
| March 31, 2021 | 326.02M |
| December 31, 2020 | 338.14M |
| September 30, 2020 | 125.41M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 486.58M |
| Total Liabilities (Quarterly) | 56.01M |
| Debt to Equity Ratio | 0.0085 |
| Current Ratio | 8.863 |
| Net Debt Paydown Yield | -0.05% |